About Prosetta
Prosetta is a company based in Mysuru (India) founded in 2004 by Karl Manheim. It operates as a B2B and Licensing. Prosetta offers products and services including Broad-Spectrum Antibiotics and Small-Molecule Drugs. Prosetta operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Mysuru, India
- Founders Karl Manheim
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Prosetta Bio-Conformatics Private Limited
- Date of Incorporation 03 Mar, 2004
- Jurisdiction Mysore, Karnataka, India
-
Annual Revenue
$199.63 K (USD)12.46as on Mar 31, 2022
-
Net Profit
$24.89 K (USD)365.51as on Mar 31, 2022
-
EBITDA
$89.3 K (USD)12.76as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prosetta
Prosetta offers a comprehensive portfolio of products and services, including Broad-Spectrum Antibiotics and Small-Molecule Drugs.
Drugs targeting multi-drug resistant pathogens for community infections.
Compounds for viral infections and cancers via novel mechanisms.
Funding Insights of Prosetta
Detailed funding history for Prosetta
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prosetta
Investment portfolio details for Prosetta
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prosetta
Detailed financials for Prosetta
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prosetta Comparisons
Peer comparison for Prosetta
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prosetta
Prosetta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Prosetta
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prosetta
Complete news archive for Prosetta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prosetta
Prosetta was founded in 2004.
Prosetta is headquartered in Mysuru, India. It is registered at Mysuru, Karnataka, India.
Annual revenue of Prosetta is $199.63K as on Mar 31, 2022.
Prosetta Bioconformatics, established in 2004, is a biotech research company based in Mysuru, India, with a parent company in San Francisco, USA. It focuses on discovering and developing novel small-molecule drugs targeting viral, bacterial infections, cancers, and neurodegenerative disorders using its unique Prosetta Paradigm platform. The company advances programs for broad-spectrum antibiotics and collaborates with pharmaceutical firms through licensing agreements, conducting efficacy studies and in-vitro research to address global health challenges.
Prosetta's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Prosetta offers Broad-Spectrum Antibiotics and Small-Molecule Drugs.